Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kayla M. Rudeen, Wenqiang Liu, William F. Mieler & Jennifer J. Kang-Mieler. (2022) Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery System. Current Eye Research 47:7, pages 1034-1042.
Read now
Read now
Articles from other publishers (6)
Eric W. Schneider, Mridul K. ThomasFranco M. Recchia, David A. Reichstein & Carl C. Awh. (2023) SUSTAINED BIWEEKLY AFLIBERCEPT FOR REFRACTORY NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina 43:5, pages 739-746.
Crossref
Crossref
Mirinae Kim, Junhyuck Lee, Young-Gun Park & Young-Hoon Park. (2022) Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization. American Journal of Ophthalmology 233, pages 18-29.
Crossref
Crossref
Chenyi Liu, Shian Zhang, Xinyi Deng, Yijing Chen, Lijun Shen, Liang Hu & Jianbo Mao. (2021) Comparison of Intraocular Cytokine Levels of Choroidal Neovascularization Secondary to Different Retinopathies. Frontiers in Medicine 8.
Crossref
Crossref
Christof Haensli, Isabel B. Pfister & Justus G. Garweg. (2021) Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes. Journal of Clinical Medicine 10:12, pages 2666.
Crossref
Crossref
María L. Formica, Hamoudi G. Awde Alfonso & Santiago D. Palma. (2021) Biological drug therapy for ocular angiogenesis: Anti‐VEGF agents and novel strategies based on nanotechnology. Pharmacology Research & Perspectives 9:2.
Crossref
Crossref
Claudio Iovino, Rodolfo Mastropasqua, Marco Lupidi, Daniela Bacherini, Marco Pellegrini, Federico Bernabei, Enrico Borrelli, Riccardo Sacconi, Adriano Carnevali, Rossella D’Aloisio, Alessio Cerquaglia, Lucia Finocchio, Andrea Govetto, Stefano Erba, Giacinto Triolo, Antonio Di Zazzo, Matteo Forlini, Aldo Vagge & Giuseppe Giannaccare. (2020) Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature. Pharmaceutics 12:8, pages 703.
Crossref
Crossref